Flourishing for Peace
Flourishing for Peace Curriculum (Currículo de Florecimiento Para la Paz)
This study is a six-arm individually randomized group-treated (IRGT) trial comparing five16-week standalone flourishing curricula conditions with a control condition consisting of the regular curriculum. Participants will be individually randomized to one of the six conditions. Self-report variables and heart rate variability (HRV) data will be assessed at four time points: T1 (baseline, before the curriculum begins), T2 (8-week midterm), T3 (16-week, at the end of the curriculum), and T4 (beginning of next term), with the main outcome testing changes between T1 and T3. Primary outcomes include the lnRMSSD as a measure of HRV and the overall self-reported flourishing score. Secondary outcomes include 20 domain specific psychological scales and two other HRV measures (SDNN, and mean heart rate). Course-specific knowledge tests will also be administered to gauge participant engagement and course effectiveness. Study results will be reported in accordance with the Consolidated Standards of Reporting Trials (CONSORT) guidelines for non-pharmacological interventions.
연구 개요
상태
상태
정황
정황
개입 / 치료
개입 / 치료
연구 유형
연구 유형
등록 (추정된)
등록
단계
단계
- 해당 없음
연락처 및 위치
연구 연락처
연구 연락처
- 이름: Andrea Ortega Bechara
- 전화번호: +573107286975
- 이메일: a.ortega.bechara@unisinu.edu.co
연구 장소
-
-
-
Montería, 콜롬비아
- Universidad del Sinú (Unisinú)
-
연락하다:
- Andrea Ortega Bechara
- 전화번호: +573107286975
- 이메일: a.ortega.bechara@unisinu.edu.co
-
-
참여기준
자격 기준
자격 기준
공부할 수 있는 나이
건강한 자원 봉사자를 받아들입니다
연구 대상 성별
설명
Inclusion Criteria:
- (a) enrollment as a university student at UniSinu; (b) intention to remain in the campus area for at least 12 months and express a commitment to try to remain engaged in the study from beginning to end; and (c) ability to read, speak, and understand Spanish.
Exclusion Criteria:
- No
공부 계획
연구는 어떻게 설계됩니까?
디자인 세부사항
- 주 목적: 기초 과학
- 할당: 무작위
- 중재 모델: 병렬 할당
- 마스킹: 삼루타
팔의 수
무기와 개입
참가자 그룹 / 팔참가자 그룹 / 팔 |
개입 / 치료개입 / 치료 |
|---|---|
|
실험적: Resilience and Self-Control
This flourishing curriculum is delivered as a stand-alone, 16-week classroom seminar incorporating lectures, experiential activities, and structured discussions. The content of this curriculum was developed by subject-matter experts. |
Resilience and Self-Control |
|
실험적: Stress, Coping, and Forgiveness
This flourishing curriculum is delivered as a stand-alone, 16-week classroom seminar incorporating lectures, experiential activities, and structured discussions. The content of this curriculum was developed by subject-matter experts. |
Stress, Coping, and Forgiveness |
|
실험적: Mindfulness and Meaning and Purpose
This flourishing curriculum combines two courses, and is delivered as a stand-alone, 16-week classroom seminar. Mindfulness will be taught in 8 of the 16 weeks and Meaning and Purpose will be taught in another 8 weeks. Contents incorporate lectures, experiential activities, and structured discussions. The content of this curriculum was developed by subject-matter experts. |
Mindfulness and Meaning and Purpose |
|
실험적: Quality of Relationships for Peace and Positive Emotions
This flourishing curriculum combines two courses, and is delivered as a stand-alone, 16-week classroom seminar. Quality of Relationships for Peace will be taught in 8 of the 16 weeks and Positive Emotions will be taught in another 8 weeks. Contents incorporate lectures, experiential activities, and structured discussions. The content of this curriculum was developed by subject-matter experts. |
Quality of Relationships for Peace and Positive Emotions |
|
실험적: Emotional Intelligence, Forgiveness, and Spirituality
This flourishing curriculum is delivered as a stand-alone, 16-week classroom seminar incorporating lectures, experiential activities, and structured discussions. The content of this curriculum was developed by subject-matter experts. |
Emotional Intelligence, Forgiveness, and Spirituality |
|
활성 비교기: Regular course
Participants assigned to the control condition will continue with their regular university coursework but complete the same measures as the intervention conditions. |
Regular course |
연구는 무엇을 측정합니까?
주요 결과 측정
주요 결과 측정
결과 측정 |
측정값 설명 |
기간 |
|---|---|---|
|
Overall Flourishing: Flourish Measure
기간: T1 Baseline, T2 End of 8 weeks, T3 End of 16 weeks, T4 6-month Follow-up
|
Use the total score across 10 items of the Flourish measure developed by Tyler VanderWeele. Scale score ranges from 0 to 10. Higher score indicates better outcome. |
T1 Baseline, T2 End of 8 weeks, T3 End of 16 weeks, T4 6-month Follow-up
|
|
lnRMSSD
기간: T1 Baseline, T2 End of 8 weeks, T3 End of 16 weeks, T4 6-month Follow-up
|
Heart rate variability (HRV) will be collected using a validated chest-strap sensor ( the Polar H10; Polar Electro, Kempele, Finland) during standardized resting assessments. The natural logarithm of the root mean square of successive differences between normal RR intervals (lnRMSSD), a time-domain measure of short-term heart rate variability and vagal/parasympathetic regulation, will be used as the primary HRV outcome. |
T1 Baseline, T2 End of 8 weeks, T3 End of 16 weeks, T4 6-month Follow-up
|
2차 결과 측정
2차 결과 측정
결과 측정 |
측정값 설명 |
기간 |
|---|---|---|
|
Happiness and Life Satisfaction: subscale of Flourish Measure
기간: T1 Baseline, T2 End of 8 weeks, T3 End of 16 weeks, T4 6-month Follow-up
|
subscale of the Flourish measure of the primary outcome developed by VanderWeele. Scale score ranges from 0 to 10. Higher score indicates better outcome. |
T1 Baseline, T2 End of 8 weeks, T3 End of 16 weeks, T4 6-month Follow-up
|
|
Mental and Physical Health: subscale of Flourish Measure
기간: T1 Baseline, T2 End of 8 weeks, T3 End of 16 weeks, T4 6-month Follow-up
|
subscale of the Flourish measure of the primary outcome developed by VanderWeele. Scale score ranges from 0 to 10. Higher score indicates better outcome. |
T1 Baseline, T2 End of 8 weeks, T3 End of 16 weeks, T4 6-month Follow-up
|
|
Meaning and Purpose: subscale of Flourish Measure
기간: T1 Baseline, T2 End of 8 weeks, T3 End of 16 weeks, T4 6-month Follow-up
|
subscale of the Flourish measure of the primary outcome developed by VanderWeele. Scale score ranges from 0 to 10. Higher score indicates better outcome. |
T1 Baseline, T2 End of 8 weeks, T3 End of 16 weeks, T4 6-month Follow-up
|
|
Character and Virtue: subscale of Flourish Measure
기간: T1 Baseline, T2 End of 8 weeks, T3 End of 16 weeks, T4 6-month Follow-up
|
subscale of the Flourish measure of the primary outcome developed by VanderWeele. Scale score ranges from 0 to 10. Higher score indicates better outcome. |
T1 Baseline, T2 End of 8 weeks, T3 End of 16 weeks, T4 6-month Follow-up
|
|
Close Social Relationships: subscale of Flourish Measure
기간: T1 Baseline, T2 End of 8 weeks, T3 End of 16 weeks, T4 6-month Follow-up
|
subscale of the Flourish measure of the primary outcome developed by VanderWeele. Scale score ranges from 0 to 10. Higher score indicates better outcome. |
T1 Baseline, T2 End of 8 weeks, T3 End of 16 weeks, T4 6-month Follow-up
|
|
Depression symptoms: Patient Health Questionnaire-9 (PHQ-9)
기간: T1 Baseline, T2 End of 8 weeks, T3 End of 16 weeks, T4 6-month Follow-up
|
Scale score ranges from 0 to 3. Higher score indicates more severe depressive symptoms. |
T1 Baseline, T2 End of 8 weeks, T3 End of 16 weeks, T4 6-month Follow-up
|
|
Anxiety Symptoms: Generalized Anxiety Disorder-7 (GAD-7)
기간: T1 Baseline, T2 End of 8 weeks, T3 End of 16 weeks, T4 6-month Follow-up
|
Scale score ranges from 0 to 3. Higher scores more severe anxiety symptoms. |
T1 Baseline, T2 End of 8 weeks, T3 End of 16 weeks, T4 6-month Follow-up
|
|
The Short Stress Overload Scale
기간: T1 Baseline, T2 End of 8 weeks, T3 End of 16 weeks, T4 6-month Follow-up
|
Scale score ranges from 1 to 5. Higher score indicates higher stress. |
T1 Baseline, T2 End of 8 weeks, T3 End of 16 weeks, T4 6-month Follow-up
|
|
Coherence: subscale of the Three Dimensional Meaning in Life Scale (3DM)
기간: T1 Baseline, T2 End of 8 weeks, T3 End of 16 weeks, T4 6-month Follow-up
|
Scale score ranges from 1 to 7. Higher score indicates higher meaning. |
T1 Baseline, T2 End of 8 weeks, T3 End of 16 weeks, T4 6-month Follow-up
|
|
Purpose: subscale of the Three Dimensional Meaning in Life Scale (3DM)
기간: T1 Baseline, T2 End of 8 weeks, T3 End of 16 weeks, T4 6-month Follow-up
|
Scale score ranges from 1 to 7. Higher score indicates higher meaning. |
T1 Baseline, T2 End of 8 weeks, T3 End of 16 weeks, T4 6-month Follow-up
|
|
Significance: subscale of the Three Dimensional Meaning in Life Scale (3DM)
기간: T1 Baseline, T2 End of 8 weeks, T3 End of 16 weeks, T4 6-month Follow-up
|
Scale score ranges from 1 to 7. Higher score indicates higher meaning. |
T1 Baseline, T2 End of 8 weeks, T3 End of 16 weeks, T4 6-month Follow-up
|
|
Trait Forgivingness Scale
기간: T1 Baseline, T2 End of 8 weeks, T3 End of 16 weeks, T4 6-month Follow-up
|
Scale score ranges from 1 to 5. Higher score indicates higher forgiveness. |
T1 Baseline, T2 End of 8 weeks, T3 End of 16 weeks, T4 6-month Follow-up
|
|
Trait Humility: subscale of Relational Humility Scale
기간: T1 Baseline, T2 End of 8 weeks, T3 End of 16 weeks, T4 6-month Follow-up
|
Scale score ranges from 1 to 5. Higher score indicates higher humility. |
T1 Baseline, T2 End of 8 weeks, T3 End of 16 weeks, T4 6-month Follow-up
|
|
Cognitive and Affective Mindfulness Scale-Revised (CAMS-R)
기간: T1 Baseline, T2 End of 8 weeks, T3 End of 16 weeks, T4 6-month Follow-up
|
Scale score ranges from 1 to 4. Higher score indicates higher mindfulness. |
T1 Baseline, T2 End of 8 weeks, T3 End of 16 weeks, T4 6-month Follow-up
|
|
Brief Self-Control Scale
기간: T1 Baseline, T2 End of 8 weeks, T3 End of 16 weeks, T4 6-month Follow-up
|
Scale score ranges from 1 to 5. Higher score indicates higher self-control |
T1 Baseline, T2 End of 8 weeks, T3 End of 16 weeks, T4 6-month Follow-up
|
|
Brief Resilience Scale
기간: T1 Baseline, T2 End of 8 weeks, T3 End of 16 weeks, T4 6-month Follow-up
|
Scale score ranges from 1 to 5. Higher score indicates higher resilience. |
T1 Baseline, T2 End of 8 weeks, T3 End of 16 weeks, T4 6-month Follow-up
|
|
Loneliness: NIH Toolbox Adult Social Relationship Scales
기간: T1 Baseline, T2 End of 8 weeks, T3 End of 16 weeks, T4 6-month Follow-up
|
Scale score ranges from 1 to 5. Higher score indicates higher level of loneliness |
T1 Baseline, T2 End of 8 weeks, T3 End of 16 weeks, T4 6-month Follow-up
|
|
Transcendent Spirituality: subscale of Trait Sources of Spirituality Scale
기간: T1 Baseline, T2 End of 8 weeks, T3 End of 16 weeks, T4 6-month Follow-up
|
Scale score ranges from 1 to 5. Higher score indicates higher level of spirituality |
T1 Baseline, T2 End of 8 weeks, T3 End of 16 weeks, T4 6-month Follow-up
|
|
Persevering Hope Scale
기간: T1 Baseline, T2 End of 8 weeks, T3 End of 16 weeks, T4 6-month Follow-up
|
Scale score ranges from 1 to 5. Higher score indicates higher level of hope |
T1 Baseline, T2 End of 8 weeks, T3 End of 16 weeks, T4 6-month Follow-up
|
|
Coping Self-Efficacy Scale
기간: T1 Baseline, T2 End of 8 weeks, T3 End of 16 weeks, T4 6-month Follow-up
|
Scale score ranges from 0 to 10. Higher score indicates higher level of self-efficacy |
T1 Baseline, T2 End of 8 weeks, T3 End of 16 weeks, T4 6-month Follow-up
|
|
SDNN
기간: T1 Baseline, T2 End of 8 weeks, T3 End of 16 weeks, T4 6-month Follow-up
|
Standard Deviation of Normal-to-Normal intervals, another HRV measure |
T1 Baseline, T2 End of 8 weeks, T3 End of 16 weeks, T4 6-month Follow-up
|
|
Mean Heart Rate
기간: T1 Baseline, T2 End of 8 weeks, T3 End of 16 weeks, T4 6-month Follow-up
|
Mean Heart Rate |
T1 Baseline, T2 End of 8 weeks, T3 End of 16 weeks, T4 6-month Follow-up
|
공동 작업자 및 조사자
연구 기록 날짜
연구 주요 날짜
연구 시작 (추정된)
연구 시작
기본 완료 (추정된)
기본 완료
연구 완료 (추정된)
연구 완료
연구 등록 날짜
최초 제출
최초 제출
QC 기준을 충족하는 최초 제출
QC 기준을 충족하는 최초 제출
처음 게시됨 (실제)
처음 게시됨
연구 기록 업데이트
마지막 업데이트 게시됨 (실제)
마지막 업데이트 게시됨
QC 기준을 충족하는 마지막 업데이트 제출
QC 기준을 충족하는 마지막 업데이트 제출
마지막으로 확인됨
마지막으로 확인됨
추가 정보
이 연구와 관련된 용어
기타 연구 ID 번호
기타 연구 ID 번호
- Acta No. 005 de 2025
개별 참가자 데이터(IPD) 계획
개별 참가자 데이터(IPD)를 공유할 계획입니까?
약물 및 장치 정보, 연구 문서
미국 FDA 규제 의약품 연구
미국 FDA 규제 기기 제품 연구
이 정보는 변경 없이 clinicaltrials.gov 웹사이트에서 직접 가져온 것입니다. 귀하의 연구 세부 정보를 변경, 제거 또는 업데이트하도록 요청하는 경우 register@clinicaltrials.gov. 문의하십시오. 변경 사항이 clinicaltrials.gov에 구현되는 즉시 저희 웹사이트에도 자동으로 업데이트됩니다. .